| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| acid sphingomyelinase | 3 | 0 | 0 | 3 |
| thioredoxin reductase | 12 | 0 | 0 | 12 |
| USP1 protein, partial | 11 | 0 | 0 | 11 |
| TDP1 protein | 21 | 0 | 0 | 21 |
| vitamin D3 receptor isoform VDRA | 5 | 0 | 0 | 5 |
| importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
| flap endonuclease 1 | 9 | 0 | 0 | 9 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 4 | 0 | 0 | 4 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 5 | 0 | 0 | 5 |
| GTP-binding nuclear protein Ran isoform 1 | 3 | 0 | 0 | 3 |
| DNA polymerase eta isoform 1 | 4 | 0 | 0 | 4 |
| DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
| urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
| plasminogen precursor | 4 | 0 | 0 | 4 |
| urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
| geminin | 18 | 0 | 0 | 18 |
| DNA polymerase kappa isoform 1 | 5 | 0 | 0 | 5 |
| fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
| Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Transthyretin | 0 | 0 | 1 | 1 |
| Fatty acid-binding protein, intestinal | 0 | 2 | 2 | 4 |
| Fatty acid-binding protein, adipocyte | 0 | 1 | 1 | 2 |
| Cyclin-A2 | 0 | 3 | 0 | 3 |
| Cannabinoid receptor 1 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 2 | 0 | 3 | 2 | 5 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 4 | 0 | 0 | 4 |
| Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
| Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| dopamine D1 receptor | 4 | 0 | 0 | 4 |
| GLS protein | 6 | 0 | 0 | 6 |
| Thrombopoietin | 6 | 0 | 0 | 6 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
| cytochrome P450 2D6 isoform 1 | 4 | 0 | 0 | 4 |
| cytochrome P450 2C19 precursor | 5 | 0 | 0 | 5 |
| ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
| histone acetyltransferase KAT2A isoform 1 | 6 | 0 | 0 | 6 |
| lethal factor (plasmid) | 5 | 0 | 0 | 5 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 3 |
| Spike glycoprotein | 13 | 0 | 0 | 13 |
| ATP-dependent phosphofructokinase | 15 | 0 | 0 | 15 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 1 | 6 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 1A | 0 | 11 | 4 | 16 |
| 5-hydroxytryptamine receptor 1B | 0 | 8 | 1 | 9 |
| 5-hydroxytryptamine receptor 1D | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 2B | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 10 | 1 | 11 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 5 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 5B | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 1 | 2 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 10 | 0 | 0 | 10 |
| Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| Chain A, Ferritin light chain | 8 | 0 | 0 | 8 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| Luciferase | 7 | 0 | 0 | 7 |
| endonuclease IV | 6 | 0 | 0 | 6 |
| glp-1 receptor, partial | 7 | 0 | 0 | 7 |
| SUMO-1-specific protease | 0 | 1 | 0 | 1 |
| ATAD5 protein, partial | 10 | 0 | 0 | 10 |
| Fumarate hydratase | 5 | 0 | 0 | 5 |
| NFKB1 protein, partial | 3 | 0 | 0 | 3 |
| PPM1D protein | 5 | 0 | 0 | 5 |
| Microtubule-associated protein tau | 10 | 0 | 0 | 10 |
| SUMO1/sentrin specific peptidase 7 | 0 | 1 | 0 | 1 |
| Smad3 | 4 | 0 | 0 | 4 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 7 | 0 | 0 | 7 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 12 | 0 | 0 | 12 |
| EWS/FLI fusion protein | 14 | 0 | 0 | 14 |
| nonstructural protein 1 | 3 | 0 | 0 | 3 |
| estrogen-related nuclear receptor alpha | 19 | 0 | 0 | 19 |
| G | 8 | 0 | 0 | 8 |
| cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
| polyprotein | 5 | 0 | 0 | 5 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| 67.9K protein | 7 | 0 | 0 | 7 |
| Parkin | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| arylsulfatase A | 12 | 0 | 0 | 12 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| LacZ protein (plasmid) | 0 | 1 | 0 | 1 |
| IDH1 | 9 | 0 | 0 | 9 |
| euchromatic histone-lysine N-methyltransferase 2 | 20 | 0 | 0 | 20 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| [Tau protein] kinase | 0 | 1 | 0 | 1 |
| Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
| cellular tumor antigen p53 isoform a | 6 | 0 | 0 | 6 |
| D(1A) dopamine receptor | 7 | 0 | 0 | 7 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 14 | 0 | 0 | 14 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 6 | 0 | 0 | 6 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 5 | 0 | 0 | 5 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 10 | 0 | 0 | 10 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| mitogen-activated protein kinase 1 | 8 | 0 | 0 | 8 |
| atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 6 | 0 | 1 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 5 | 0 | 0 | 5 |
| matrix metalloproteinase-14 preproprotein | 0 | 1 | 0 | 1 |
| tyrosine-protein kinase Yes | 2 | 0 | 0 | 2 |
| melanocortin receptor 4 | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
| nuclear receptor ROR-gamma isoform 1 | 8 | 0 | 0 | 8 |
| survival motor neuron protein isoform d | 9 | 0 | 0 | 9 |
| cytochrome P450 3A4 isoform 1 | 8 | 0 | 0 | 8 |
| M-phase phosphoprotein 8 | 7 | 0 | 0 | 7 |
| transient receptor potential cation channel subfamily V member 1 | 2 | 0 | 0 | 2 |
| glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 2 |
| muscleblind-like protein 1 isoform 1 | 6 | 0 | 0 | 6 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| muscarinic acetylcholine receptor M1 | 9 | 0 | 0 | 9 |
| sentrin-specific protease 8 | 0 | 1 | 0 | 1 |
| lamin isoform A-delta10 | 18 | 0 | 0 | 18 |
| pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
| chaperonin GroEL | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | 8 | 2 | 3 | 13 |
| Aurora kinase A | 0 | 1 | 0 | 1 |
| Casein kinase I isoform alpha | 0 | 1 | 0 | 1 |
| Cyclin-T1 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B2 | 0 | 3 | 0 | 3 |
| Interferon beta | 11 | 0 | 0 | 11 |
| HLA class I histocompatibility antigen, B alpha chain | 8 | 0 | 0 | 8 |
| Amyloid-beta precursor protein | 1 | 2 | 0 | 3 |
| Integrin beta-3 | 4 | 0 | 0 | 4 |
| Estrogen receptor | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 1 | 0 | 3 | 0 | 3 |
| Integrin alpha-IIb | 4 | 0 | 0 | 4 |
| Ornithine decarboxylase | 1 | 0 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 4 | 0 | 2 | 0 | 2 |
| G2/mitotic-specific cyclin-B1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 8 | 2 | 3 | 13 |
| Gamma-aminobutyric acid receptor subunit delta | 8 | 2 | 3 | 13 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 8 | 2 | 3 | 13 |
| Interferon-induced, double-stranded RNA-activated protein kinase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 8 | 2 | 3 | 13 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 8 | 2 | 3 | 13 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 8 | 2 | 3 | 13 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 8 | 2 | 3 | 13 |
| G1/S-specific cyclin-D1 | 0 | 2 | 0 | 2 |
| G1/S-specific cyclin-E1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 8 | 2 | 3 | 13 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 8 | 2 | 3 | 13 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 8 | 2 | 3 | 13 |
| Dual specificity protein kinase CLK1 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 alpha | 0 | 4 | 0 | 4 |
| Glycogen synthase kinase-3 beta | 0 | 3 | 2 | 5 |
| D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
| Cyclin-dependent kinase 7 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 9 | 0 | 1 | 0 | 1 |
| Cyclin-H | 0 | 1 | 0 | 1 |
| CDK-activating kinase assembly factor MAT1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 8 | 2 | 3 | 13 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 8 | 2 | 3 | 13 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 8 | 2 | 3 | 13 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B3 | 0 | 3 | 0 | 3 |
| GABA theta subunit | 8 | 2 | 3 | 13 |
| Inositol hexakisphosphate kinase 1 | 8 | 0 | 0 | 8 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 2 | 0 | 1 | 0 | 1 |
| Aurora kinase B | 0 | 1 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 8 | 2 | 3 | 13 |
| Aurora kinase C | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 8 | 0 | 0 | 8 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 8 | 0 | 9 |
| Beta-2 adrenergic receptor | 0 | 15 | 11 | 27 |
| Beta-1 adrenergic receptor | 0 | 16 | 10 | 26 |
| Beta-3 adrenergic receptor | 0 | 10 | 9 | 19 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 9 | 0 | 0 | 9 |
| RAR-related orphan receptor gamma | 17 | 0 | 0 | 17 |
| retinoid X nuclear receptor alpha | 11 | 0 | 0 | 11 |
| peroxisome proliferator activated receptor gamma | 10 | 0 | 0 | 10 |
| thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
| AR protein | 25 | 0 | 0 | 25 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| glucocorticoid receptor [Homo sapiens] | 16 | 0 | 0 | 16 |
| estrogen nuclear receptor alpha | 21 | 0 | 0 | 21 |
| NPYLR7B | 0 | 0 | 4 | 4 |
| Histone H2A.x | 8 | 0 | 0 | 8 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
| peripheral myelin protein 22 | 10 | 0 | 0 | 10 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
| Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
| Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 9 | 0 | 0 | 9 |
| Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Avidin | 0 | 0 | 1 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
| Insulin receptor | 0 | 1 | 0 | 2 |
| Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 2 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 0 | 1 |
| Adenosine receptor A3 | 0 | 7 | 3 | 11 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 1 | 0 | 2 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Endoplasmin | 0 | 1 | 1 | 2 |
| Glutamate receptor 2 | 10 | 0 | 0 | 10 |
| Inosine-5'-monophosphate dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 4 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
| Streptavidin | 0 | 0 | 1 | 1 |
| Adenosylhomocysteinase | 0 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 1 | 2 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 3 | 6 |
| Adenosine receptor A2b | 0 | 0 | 1 | 2 |
| Adenosine receptor A2b | 0 | 1 | 1 | 2 |
| Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 2 | 5 |
| Adenosine receptor A2a | 0 | 1 | 1 | 2 |
| Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 1 | 1 | 2 |
| Adenosine kinase | 0 | 0 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 3 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 3 |
| Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
| Adenosine kinase | 0 | 1 | 0 | 2 |
| Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 3 |
| 5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
| Adenosine transporter 1 | 0 | 0 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 21 | 0 | 21 |
| Multidrug resistance-associated protein 4 | 0 | 21 | 0 | 22 |
| Bile salt export pump | 0 | 24 | 0 | 24 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 1 | 5 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 3 | 6 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 7 | 10 |
| Canalicular multispecific organic anion transporter 1 | 0 | 21 | 0 | 21 |
| acetylcholinesterase | 4 | 0 | 0 | 4 |
| phosphopantetheinyl transferase | 8 | 0 | 0 | 8 |
| hypoxia-inducible factor 1 alpha subunit | 5 | 0 | 0 | 5 |
| SMAD family member 2 | 5 | 0 | 0 | 5 |
| SMAD family member 3 | 5 | 0 | 0 | 5 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | 7 | 0 | 0 | 7 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| estrogen receptor 2 (ER beta) | 10 | 0 | 0 | 10 |
| nuclear receptor subfamily 1, group I, member 3 | 15 | 0 | 0 | 15 |
| progesterone receptor | 9 | 0 | 0 | 9 |
| retinoic acid nuclear receptor alpha variant 1 | 13 | 0 | 0 | 13 |
| farnesoid X nuclear receptor | 11 | 0 | 0 | 11 |
| pregnane X nuclear receptor | 12 | 0 | 0 | 12 |
| peroxisome proliferator-activated receptor delta | 9 | 0 | 0 | 9 |
| caspase-3 | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 8 | 0 | 0 | 8 |
| cytochrome P450 2C9 precursor | 5 | 0 | 0 | 5 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform 2 | 15 | 0 | 0 | 15 |
| heat shock protein beta-1 | 5 | 0 | 0 | 5 |
| huntingtin isoform 2 | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 14 | 0 | 0 | 14 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 4 | 0 | 10 | 1 | 11 |
| Lysine-specific demethylase PHF2 | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
| Cellular tumor antigen p53 | 12 | 0 | 0 | 12 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 4 |
| Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 1 | 4 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 14 | 2 | 27 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 7 | 2 | 10 |
| Cytochrome P450 2C8 | 0 | 3 | 0 | 3 |
| Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 1 | 4 |
| D(2) dopamine receptor | 0 | 7 | 1 | 8 |
| Androgen receptor | 0 | 5 | 0 | 6 |
| Alpha-1B adrenergic receptor | 0 | 7 | 1 | 8 |
| Lethal factor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 4 | 1 | 6 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 3 | 1 | 4 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 5 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 6 | 1 | 7 |
| D(4) dopamine receptor | 0 | 4 | 0 | 4 |
| Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 8 | 1 | 9 |
| Histamine H2 receptor | 0 | 4 | 0 | 4 |
| Endothelin-1 receptor | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 10 | 1 | 11 |
| 5-hydroxytryptamine receptor 2C | 0 | 10 | 1 | 11 |
| Lysine-specific demethylase 5A | 0 | 1 | 0 | 1 |
| B2 bradykinin receptor | 0 | 2 | 0 | 2 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 5 | 2 | 7 |
| D(3) dopamine receptor | 0 | 10 | 0 | 10 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 3 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 5 | 1 | 6 |
| Kappa-type opioid receptor | 0 | 5 | 1 | 6 |
| 5-hydroxytryptamine receptor 2B | 0 | 10 | 1 | 11 |
| C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 7 | 1 | 8 |
| Histamine H2 receptor | 6 | 0 | 1 | 7 |
| 5-hydroxytryptamine receptor 6 | 0 | 6 | 1 | 7 |
| Carnitine O-palmitoyltransferase 1, liver isoform | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 4 | 0 | 2 | 0 | 2 |
| Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 6 | 0 | 6 |
| Sodium-dependent dopamine transporter | 0 | 8 | 0 | 8 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 11 | 0 | 11 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 6 | 0 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 7 | 0 | 7 |
| Sodium channel protein type 5 subunit alpha | 0 | 7 | 0 | 7 |
| Squalene monooxygenase | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 4 | 0 | 4 |
| Lysine-specific demethylase 7A | 0 | 1 | 0 | 1 |
| Carnitine O-palmitoyltransferase 1, muscle isoform | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
| Ataxin-2 | 12 | 0 | 0 | 12 |
| Sigma non-opioid intracellular receptor 1 | 0 | 8 | 0 | 8 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 0 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 11 subunit alpha | 0 | 2 | 0 | 2 |
| Histone lysine demethylase PHF8 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
| Chain A, Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor) | 0 | 1 | 0 | 1 |
| Coagulation factor X | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 2 | 0 | 2 |
| Coagulation factor X | 0 | 2 | 0 | 2 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Trypsin-2 | 0 | 1 | 0 | 1 |
| Trypsin-3 | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 4 | 7 |
| Fatty acid-binding protein, liver | 0 | 3 | 1 | 4 |
| Urease | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 3 | 2 | 6 |
| Alpha-1A adrenergic receptor | 0 | 2 | 3 | 6 |
| Alpha-1B adrenergic receptor | 0 | 1 | 2 | 4 |
| TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
| Amine oxidase [flavin-containing] A | 0 | 0 | 1 | 1 |
| Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 1 | 2 |
| Atrial natriuretic peptide receptor 1 | 0 | 1 | 1 | 2 |
| Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| GLI family zinc finger 3 | 15 | 0 | 0 | 15 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| P53 | 1 | 0 | 0 | 1 |
| aryl hydrocarbon receptor | 7 | 0 | 0 | 7 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 10 | 0 | 0 | 10 |
| activating transcription factor 6 | 7 | 0 | 0 | 7 |
| hemoglobin subunit beta | 2 | 0 | 0 | 2 |
| Bile salt export pump | 0 | 6 | 0 | 6 |
| Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
| ATPase family AAA domain-containing protein 5 | 8 | 0 | 0 | 8 |
| Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 4 | 1 | 5 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
| Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
| Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 2 |
| Renin | 0 | 1 | 0 | 1 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Leukotriene A-4 hydrolase | 0 | 2 | 1 | 3 |
| EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 4 | 1 | 5 |
| Angiotensin-converting enzyme | 0 | 6 | 0 | 7 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Thymidine phosphorylase | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
| Succinyl-diaminopimelate desuccinylase | 0 | 3 | 0 | 3 |
| Angiotensin-converting enzyme | 0 | 3 | 0 | 3 |
| Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
| Beta-lactamase TEM | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 3 | 1 | 4 |
| Beta-lactamase | 0 | 2 | 0 | 3 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme 2 | 0 | 2 | 0 | 2 |
| Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| Toll-like receptor 4 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 3 | 0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 3 | 2 | 6 |
| UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 2 |
| Potassium channel subfamily K member 10 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 6 | 0 | 6 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 9 | 0 | 0 | 9 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| Caspase-2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Chk1 | 0 | 1 | 0 | 1 |
| 3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
| Insulin-like growth factor 1 receptor | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
| Casein kinase I isoform epsilon | 0 | 1 | 0 | 1 |
| Angiopoietin-1 receptor | 0 | 1 | 0 | 1 |
| Protein kinase C zeta type | 0 | 1 | 0 | 1 |
| Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
| Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 2 |
| Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| D | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 3 | 1 | 4 |
| Alpha-2C adrenergic receptor | 0 | 3 | 1 | 4 |
| Alpha-2A adrenergic receptor | 0 | 3 | 1 | 4 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 1 | 2 |
| Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 1 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 2 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| Transporter | 0 | 2 | 0 | 2 |
| PAX8 | 0 | 0 | 0 | 3 |
| pregnane X receptor | 3 | 0 | 0 | 3 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 2 | 0 | 2 |
| steroidogenic factor 1 | 0 | 2 | 0 | 2 |
| caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Tubulin alpha-1A chain | 0 | 2 | 1 | 3 |
| Tubulin beta chain | 0 | 2 | 1 | 3 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Tubulin beta-4A chain | 0 | 2 | 2 | 5 |
| Tubulin beta chain | 0 | 2 | 2 | 5 |
| Cytochrome P450 3A4 | 0 | 4 | 0 | 4 |
| Tubulin alpha-3C chain | 0 | 2 | 2 | 5 |
| Serine/threonine-protein kinase pim-1 | 0 | 1 | 0 | 1 |
| Tubulin alpha-1B chain | 0 | 2 | 2 | 5 |
| Tubulin alpha-4A chain | 0 | 2 | 2 | 5 |
| Tubulin beta-4B chain | 0 | 2 | 2 | 5 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Tubulin beta-3 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2A chain | 0 | 2 | 2 | 5 |
| Tubulin polymerization-promoting protein | 0 | 0 | 1 | 1 |
| Tubulin beta-8 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2B chain | 0 | 3 | 0 | 3 |
| Tubulin alpha-3E chain | 0 | 2 | 2 | 5 |
| Tubulin alpha-1A chain | 0 | 2 | 2 | 5 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| CREB-binding protein | 1 | 0 | 0 | 1 |
| Tubulin alpha-1C chain | 0 | 2 | 2 | 5 |
| Tubulin beta-6 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2B chain | 0 | 2 | 2 | 5 |
| Tubulin beta-1 chain | 0 | 2 | 2 | 5 |
| Deoxycytidine kinase | 0 | 0 | 0 | 1 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 2 | 0 | 2 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
| nuclear receptor coactivator 3 isoform a | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Cholinesterase | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 2 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
| Peroxisome proliferator-activated receptor alpha | 0 | 0 | 1 | 1 |
| Cruzipain | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor alpha | 0 | 0 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 1 | 1 | 2 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| Peroxisome proliferator-activated receptor alpha | 0 | 1 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 1 | 5 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 0 | 4 |
| Mu-type opioid receptor | 0 | 5 | 1 | 6 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 3 | 0 | 3 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 9 | 0 | 9 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 3 | 0 | 3 |
| Cytochrome P450 2J2 | 0 | 8 | 0 | 8 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 1 | 0 | 4 | 0 | 5 |
| Carbonic anhydrase 2 | 0 | 5 | 1 | 7 |
| Albumin | 0 | 3 | 2 | 5 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 4 | 0 | 5 |
| Carbonic anhydrase 6 | 0 | 2 | 0 | 3 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 3 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
| Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 14 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Hsf1 protein | 0 | 0 | 1 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 4 | 1 | 6 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 5 | 3 | 10 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-1D adrenergic receptor | 0 | 3 | 1 | 4 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 3 | 1 | 4 |
| Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 3 | 0 | 3 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
| Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | 0 | 0 | 1 | 1 |
| Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | 0 | 0 | 1 | 1 |
| Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | 0 | 0 | 1 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 3 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 2 | 4 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 2 | 1 | 5 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 4 | 0 | 4 |
| Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| GALC protein | 1 | 0 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 4 | 1 | 5 |
| Glucocorticoid receptor | 0 | 6 | 3 | 14 |
| Progesterone receptor | 0 | 4 | 1 | 6 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 4 | 1 | 6 |
| Androgen receptor | 0 | 4 | 1 | 5 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 3 | 1 | 4 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Type-1 angiotensin II receptor | 0 | 3 | 2 | 6 |
| Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
| Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
| Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
| Multidrug resistance protein 1a | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| RGS12 | 1 | 0 | 0 | 1 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
| tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Cyclin-A1 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 0 | 1 | 1 |
| Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
| Amino acid transporter | 0 | 1 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Thymidine phosphorylase | 0 | 1 | 0 | 1 |
| Thromboxane A2 receptor | 0 | 0 | 0 | 1 |
| Type-1A angiotensin II receptor | 0 | 1 | 1 | 2 |
| Type-1B angiotensin II receptor | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Platelet glycoprotein VI | 0 | 0 | 1 | 1 |
| Glycoprotein | 0 | 1 | 0 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |